Author:
Chauhan Nutan,Singh Shailza
Abstract
AbstractPresent work aims to utilize systems biology and molecular modelling approach to understand the inhibition kinetics of Leishmania major GLO I and identifying potential hit followed by their validation through in vitro and animal studies. Simulation of GLO I inhibition has shown to affect reaction fluxes of almost all reactions in the model that led to increased production of various AGEs and free radicals. Further, in vitro testing of C1 and C2, selected through molecular modelling revealed remarkable morphological alterations like size reduction, membrane blebbing and loss in motility of the parasite, however, only C1 showed better antileishmanial activity. Additionally, C1 showed apoptosis mediated leishmanicidal activity (apoptosis-like cell death) along with cell-cycle arrest at sub-G0/G1 phase and exhibited potent anti-leishmanial effect against intracellular amastigotes. Furthermore, decrease in parasite load was also observed in C1 treated BALB/c female mice. Our results indicate that C1 has healing effect in infected mice and effectively reduced the parasitic burden. Hence, we suggest C1 as a lead molecule which on further modification, may be used to develop novel therapeutics against Leishmaniasis.
Funder
DST | Science and Engineering Research Board
Publisher
Springer Science and Business Media LLC
Reference67 articles.
1. Narain, J. P. et al. Elimination of neglected tropical diseases in the South-East Asia Region of the World Health Organization. Bull World Health Organ. 88, 206–210 (2010).
2. WHO. Accelerating Work to Overcome the Global Impact of Neglected Tropical Dieases: A Roadmap for implementation, http://www.who.int/neglected_diseases/NTD_RoadMap_2012_Fullversion.pdf. (2011).
3. Hornberg, J. J., Bruggeman, F. J., Bakker, B. M. & Westerhoff, H. V. Metabolic control analysis to identify optimal drug targets. Prog. Drug Res. 64(171), 173–189 (2007).
4. Moreno-Sanchez, R. et al. Metabolic control analysis indicates a change of strategy in the treatment of cancer. Mitochondrion. 10, 626–639 (2010).
5. Klipp, E., Wade, R. C. & Kummer, U. Biochemical network-based drug-target prediction. Curr. Opin. Biotechnol. 21, 511–516 (2010).